Market Insights
This report on the drug abuse testing/screening market studies various test and location types. For decades, drug abuse test samples were transferred to laboratories with results returned days or weeks later. More recently, point-of-collection (POC) testing became omnipresent, permitting the detection of some drugs and/or their metabolites within minutes of collection. According to market experts, leading countries from North America and Europe are applying drug abuse tests at several organizational levels, such as on-the-spot drug/alcohol screening, post-incident drug/alcohol screening, pre-employment screening, and abstinence monitoring. Government regulations and policies in these countries are assisting the growth of the drug abuse testing market, mainly through drug testing in the workplace.
For this study, based on test type, the global drug abuse testing/screening market is segmented into urine drug tests, oral fluid drug tests, hair drug tests, blood drug tests, and other drug tests. Market size estimates and forecasts for these segments for 2013 to 2022 are provided in terms of USD Mn, along with the respective compounded annual growth rates (CAGRs) for the period 2016 to 2022, considering 2015 as the base year.
Based on location type drug abuse, the testing/screening market is segmented as on-site and laboratory-based screening. Laboratory-based tests possess skilled and trained personnel for providing detailed analysis and onsite drugs of abuse testing to provide immediate results. Market size estimates and forecasts for these segments for 2013 to 2022 are provided in terms of USD Mn, along with the respective compounded annual growth rates (CAGRs) for the period 2016 to 2022, considering 2015 as the base year.
The drug abuse testing/screening market has been geographically categorized into North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa. Each geography market is further split to provide market revenue for select countries such as the U.S., Canada, the U.K., Germany, China, Japan, Brazil, and GCC countries. Market size and forecast for these segments from 2013 to 2022 and their CAGRs for the period 2016 to 2022 are provided in this report.
The major key players in the drug abuse testing/screening market are business description, financial health, budget allocation, product portfolio, and news coverage. The key players profiled in this report are Thermo Fisher Scientific, LabCorp (Laboratory Corporation of America), Abbott Laboratories, Psychemedics Corporation, Sonic Healthcare, Bio-Rad Laboratories, Alere, Inc., F. Hoffman-La Roche, Quest Diagnostics, and Randox Laboratories.
Based on the type of location, the global drug abuse testing/screening market is segmented as follows:
- On-site Screening
- Laboratory-based Screening
In the year 2015, the laboratory-based screening segment accounted for the largest market share in the global drug of abuse testing market. One of the key requirements of laboratory-based drug abuse test locations is trained and skilled personnel to provide accurate results and in-depth analysis. In laboratory-based screening tests, usually, the test is reconfirmed using gas chromatography/mass spectrometry or any other advanced techniques to provide accurate results. On the other hand, an on-site drug screening test provides accurate results, and it is generally preferred for those who take the drug test at home, in the workplace, and in educational institutions.
Based on the type of test, the drug of abuse testing/screening market is segmented into:
- Urine Drug Tests
- Oral Fluid Drug Tests
- Hair Drug Tests
- Blood Drug Tests
- Other Drug Tests
In the base year 2015, the urine and oral fluid drug tests collectively attribute the largest share in the market in terms of revenue (USD). According to Quest Diagnostics, Inc., urine drug testing detects recent drug use and is the only testing method approved for federally-mandated testing. End-users seemed to rely on laboratory-based urine testing for its cost-effectiveness and capacity to screen for various drug substances. Urine testing was the most common screening method and detects recent use, typically in the previous one to three days. Its application is also apt for all testing reasons – from pre-employment to random to post-accident – and can be performed for many illicit and prescription drugs. Market experts also suggest that despite the market entry of novel solutions and products, lab-based urine drug testing is still the gold standard in employee drug testing.
For this study, the global drug abuse testing or screening market is categorized into:
- North America
- Europe
- Asia Pacific
- Latin America (LATAM)
- The Middle East and Africa (MEA)
In 2015, North America accounted for the largest share of the global drug abuse testing/screening market, followed by Asia-Pacific, Europe, LATAM, and MEA. The Asia-Pacific region (comprising Japan, China, and India as major countries) is anticipated to grow at the fastest CAGR during 2016 – 2022. The key factors, such as the enormous production of illicit drugs, their illegal trade, and increasing consumption, have encouraged companies in North America and Europe to conduct drug screening tests such as pre-employment screening, abstinence monitoring, post-incident drug/alcohol screening, and random drug/alcohol screening. In addition, other factors, such as government regulations supporting the screening of drug abuse at workplaces, have also assisted the growth of the drug abuse testing market throughout the forecast period.
